Eventide Asset Management LLC

Eventide Asset Management LLC

Eventide Asset Management LLC

Overview
Date Founded

2008

Headquarters

1 International Place,Suite 4210,Boston, MA 02110-4201

Type of Company

Private

Employees (Worldwide)

29

Industries

Investment Services & Portfolio Management

Company Description

Eventide Asset Management is a leader in faith-based on socially responsible investing value-oriented, socially responsible investment manager.The Eventide Fund seeks to provide long-term capital appreciation. It invests primarily in a broad range of equity securities and is not restricted by market-cap. The fund may invest, without limitation, in securities in companies domiciled outside the US either directly or through ADRs. Historically, the fund has had a small/mid-cap growth emphasis. The fund tends to overweight in the healthcare sector.The Eventide Healthcare & Life Sciences Fund is a non-diversified mutual fund investing in the healthcare and life sciences sector. The fund uses bottom-up fundamental research to find companies with the potential to appreciate in value as positive data is released regarding clinical trials and FDA feedback, and market acceptance of products. Under normal market conditions, the fund invests at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences sectors.The Eventide Multi-Asset Income Fund seeks current income while maintaining the potential for capital appreciation. The fund has the flexibility to achieve its investment objective by primarily investing in a broad universe of income-producing securities. These securities include debt and equity securities of companies in the U.S. and other markets around the world. These securities may include but are not limited to common stocks, real estate investment trusts (REITs), business development companies, yieldcos, master limited partnerships (MLPs), preferred stocks, corporate bonds, government agency bonds, certificates of deposit, municipal bonds, inflation-linked bonds, mortgage-backed securities, options, exchange traded notes, ETFs, and other investment companies (including mutual funds and closed-end funds). The Fund may invest up to 15% of its net assets in companies whose securities may have legal or contractual restrictions on resale or are otherwise illiquid.The Global Dividends Opportunities Fund Seeks to provide dividend income and long-term capital appreciation with a secondary objective of dividend growth. Is is a globally diversified equity fund representing Eventide's \"best ideas\" approach to dividend-paying stocks. The fund invests globally across industry sectors and market capitalizations through both traditional and non- traditional equity income categories.

Contact Data
Trying to get in touch with decision makers at Eventide Asset Management LLC? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder & Portfolio Manager

Founding Member

Founding Member

Managing Partner

Chief Compliance Officer & General Counsel

Portfolio Manager, Income Investments

Limited Member

Limited Member

Limited Member

Paths to Eventide Asset Management LLC
Potential Connections via
Relationship Science
You
Eventide Asset Management LLC
Investments
Details Hidden

Karuna Therapeutics, Inc. operates as a clinical-stage company that targeting muscarinic receptors for the treatment of CNS disorders. It develops treatments for people afflicted with schizophrenia. The firm researches mechanism-of-action agents, and these drug-like molecules aim to improve the social and cognitive deficits of schizophrenia. The company was founded in 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.

Details Hidden

Peloton Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in translating novel scientific insights into medicines for patients with cancer and other debilitating or life-threatening conditions. Its lead drug candidate is a small molecule which targets HIF-2a, a transcription factor implicated in the development and progression of renal and other cancers. The company was founded by Steven L. McKnight in August 2010 and is headquartered in Dallas, TX.

Details Hidden

Beta Bionics, Inc. designs, manufactures and markets medical technology. It develops iLet, a bionic pancreas device for people with diabetes. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Eventide Asset Management LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Eventide Asset Management LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Eventide Asset Management LLC.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/eventide-asset-management-llc-195521
  • https://relationshipscience.com/organization/eventide-asset-management-llc-195521